Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Bullboard Posts
Comment by FredTheVoiceon Jun 25, 2018 11:30am
178 Views
Post# 28223999

RE:price

RE:price
IMB: great question. Here, like sometimes in life, I am stunned by the reaction of the stock. But, I guess we all need a little pull back to after a while, see the light. Could it be a candle just going up after a great run, and after all those good news. It seems like the market is asking now those questions:

1. are those sells of TROGARZO are continuing as mentioned in the first weeks ? And are rumors in China will implement ?;
2. will TH, sooner than later, see some green on the sheets (positive EPS); the indication will come with the second quarter earnings;
3. will TANGUAY do what he said he would with ACQUISITION of a new drug to improve the company and earnings ? When ?;

Those answers will be clarified in the next few months (My guess: a little in july, and lots more before october).

I was wrong: I though the stock would move to 15-16$ this summer. The reality is showing us that the market is waiting for answers before giving another 30-40% to the stock; some will leave the boat, some by lack of patience will miss the next drive to the sky that will come.

AND it will be coming.

FTV.
Bullboard Posts